Discovery that specific protein modification important in cancer development

February 1, 2013
Visualising DNA (blue) and HSP70 (green) during cell division shows that methylated HSP70 associates with DNA (top row), but unmethylated HSP70 is distributed throughout the rest of the cell (bottom row). Credit:

All proteins are made from chains of amino acids and their functions can be modified by adding small molecules to specific amino acids. One such modification is the addition of a methyl group, which is made of one carbon and three hydrogen atoms, that is attached to the amino acids lysine or arginine. This methylation occurs in many proteins, but its function is unclear.

Heat-shock protein 70 () is one protein that is methylated on a specific lysine amino acid. HSP70 is found in all animals and plays a role in many biochemical processes within cells. Other HSP70 modifications have been directly linked to diseases such as cancer and Parkinson's disease. Now, an international team, including researchers at the RIKEN Advanced Science Institute, Japan, has demonstrated that lysine methylation has similar implications.

Staining HSP70 with fluorescent markers showed that the methylated protein was concentrated in the chromosomes, while the unmethylated protein was spread throughout the cell, outside of the chromosomes. By capturing the methylated protein from cells and identifying the proteins that came with it, the team found an important interaction with an enzyme called Aurora kinase B (AURKB).

"AURKB is an important protein that promotes cell cycle progression and can encourage cancer ," explains co-author Minoru Yoshida. "Indeed, its expression is often deregulated in cancer and its inhibitors have been developed for ."

AURKB activity was enhanced by its interaction with HSP70, and introducing mutant HSP70 into showed that this interaction altered cell growth: HSP70 methylation accelerated cell growth and division. Having found that levels of methylated HSP70 are higher than normal in cultured and tissue from human cancer patients, the team concluded that the modification of the protein is important in the development of cancer.

Despite these findings, Yoshida says there is still much to understand about HSP70 methylation: "It is necessary to do more detailed analyses of why HSP70 is highly methylated in , how it is specifically localized in the nucleus, and how it activates AURKB," he says. But he also thinks that this work provides a new tool in the battle against the disease. "We expect that methylated HSP70 will be a remarkable new cancer diagnosis marker," he says. "As for therapy, not only AURKB inhibitors but also HSP70 methylation inhibitors or a combination of both will be new chemotherapeutic strategies in future."

Explore further: How protein networks stabilize muscle fibers: Same mechanism as for DNA

More information: Cho, H-S., et al. Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B. Nature Communications 3, 1072 (2012). … c_id=NCOMMS-20120918

Related Stories

How protein networks stabilize muscle fibers: Same mechanism as for DNA

January 23, 2012
The same mechanism that stabilises the DNA in the cell nucleus is also important for the structure and function of vertebrate muscle cells. This has been established by RUB-researchers led by Prof. Dr. Wolfgang Linke (Institute ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.